MU Stage1 Final Rule - Drug-Formulary Checks

SECTION #  Section 170.302(a)—Drug-Drug, Drug-Allergy, Drug-Formulary Checks

MU OBJECTIVE Implement drug-formulary checks

MU STAGE 1 MEASURE The EP/eligible hospital/CAH has enabled this functionality and has access to at least one internal or external drug formulary for the entire EHR reporting period.

CERTIFICATION CRITERION Final Rule Text: §170.302(b). Drug-formulary checks. Enable a user to electronically check if drugs are in a formulary or preferred drug list.

STANDARDS N/A

TEST CRITERIA # §170.302(b) http://healthcare.nist.gov/docs/170.302.b_DrugFormularyChecks_v1.1.pdf

SOLUTION DESIGN / TECHNOLOGY (Add details here)

SOLUTION COMPONENTS (Add details here - Ex. KIDS patch, Delphi code, User guide, Web resources, Manual test script, etc)

DEPENDENCIES (Add details here)

COMMENTS / NOTES (Add details here)

PREVIOUS NOTES

Note: VistA currently doesn't maintain formularies. This will need to be done with an interface to a 3rd party Application, such as the NewCrop ePrescibing service. Drug interactions are handled in VistA but because of the additional requirements, the current approach is that ePrescribing is used to check for allergies and interactions as part of that service using the drug database of the ePrescribing service. The first service being interfaced with it the NewCrop service which uses the First Databank Database that is the same one the VA was slated to use. The VA was slated to release the source code for that project but the project was stopped as it was running over budget and is under review, so we can't expect any help from the VA code anytime soon. The work being done and funded by Oroville hospital as an extension of the CCR-CCD project to provide ePrescribing is vital to this effort. It will be released as open source when it is completed.

Eventually the code for ePrescibing can potentially come ""in house"" so that VistA instances can become their own ePrescribing service with interfaces to the insurance eligibility and formulary databases (proprietary), Sure Scripts and the commercial drug databases, but Phase one of this effort is to use the ePrescibing service software provided by the ePrescribing service and to send demographics, allergies and medication lists to the service and to return lists augmented by additional information brought back from the service, i.e., additional allergies and medications provided by other providers, etc. The third item may be difficult to provide in the setting of using the ePrescribing service.

DEVELOPMENT STATUS (Add details here)

Action ITEMS / NEXT STEPS (Add details here)

OPEN ISSUES / QUESTIONS (Add details here)